Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - metformini hydrochloridum, sitagliptinum - compresse rivestite con film - metformini hydrochloridum 1000 mg, sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, cellulosum microcristallinum, povidonum k 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), macrogola, talcum, e 171, e 172 (rubrum), e 172 (nigrum), pro compresso obducto corresp. natrium 2.05 mg. - diabetes typ 2 - synthetika

Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

streuli pharma ag - metformini hydrochloridum - compresse rivestite con film - metformini hydrochloridum 500 mg, excipiens pro compresso haze. - farmaco antidiabetico orale - synthetika

Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

streuli pharma ag - metformini hydrochloridum - compresse rivestite con film - metformini hydrochloridum 850 mg, excipiens pro compresso haze. - farmaco antidiabetico orale - synthetika

Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

streuli pharma ag - metformini hydrochloridum - compresse rivestite con film - metformini hydrochloridum 1000 mg, excipiens pro compresso haze. - farmaco antidiabetico orale - synthetika

Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

actavis switzerland ag - metformini hydrochloridum - filmtabletten - metformini hydrochloridum 500 mg, excipiens pro compresso obducto. - orales antidiabetikum - synthetika human

Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

actavis switzerland ag - metformini hydrochloridum - filmtabletten - metformini hydrochloridum 850 mg, excipiens pro compresso obducto. - orales antidiabetikum - synthetika human

Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

actavis switzerland ag - metformini hydrochloridum - filmtabletten - metformini hydrochloridum 1000 mg, excipiens pro compresso obducto. - orales antidiabetikum - synthetika human

União Europeia - italiano - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabete mellito, tipo 2 - farmaci usati nel diabete - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , triplice terapia di associazione) in aggiunta alla dieta e all'esercizio fisico in pazienti non adeguatamente controllati il loro dosaggio massimo tollerato di metformina ed una sulfonilurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Itália - italiano - AIFA (Agenzia Italiana del Farmaco)

tecnigen s.r.l. - metformina e pioglitazone - metformina e pioglitazone

Itália - italiano - AIFA (Agenzia Italiana del Farmaco)

doc generici srl - metformina e pioglitazone - metformina e pioglitazone